ValuEngine lowered shares of MetLife (NYSE:MET) from a buy rating to a hold rating in a report released on Friday, April 6th.
MET has been the topic of a number of other reports. Wells Fargo reiterated a buy rating and set a $60.00 price objective on shares of MetLife in a research note on Friday, March 16th. Zacks Investment Research downgraded shares of MetLife from a hold rating to a sell rating in a research note on Tuesday, January 2nd. Bank of America started coverage on shares of MetLife in a research note on Monday, March 26th. They issued a neutral rating and a $50.00 target price for the company. Deutsche Bank started coverage on shares of MetLife in a research note on Tuesday, January 2nd. They issued a hold rating and a $55.00 target price for the company. Finally, Morgan Stanley lowered their target price on shares of MetLife from $58.00 to $56.00 and set an equal weight rating for the company in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of $56.75.
Shares of NYSE:MET opened at $47.40 on Friday. The company has a market cap of $49,230.18, a PE ratio of 10.53, a P/E/G ratio of 0.84 and a beta of 1.24. MetLife has a one year low of $43.38 and a one year high of $55.91. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.15 and a current ratio of 0.15.
Institutional investors have recently modified their holdings of the stock. First Fiduciary Investment Counsel Inc. raised its holdings in shares of MetLife by 3.1% during the fourth quarter. First Fiduciary Investment Counsel Inc. now owns 316,150 shares of the financial services provider’s stock worth $15,985,000 after purchasing an additional 9,465 shares during the last quarter. Snow Capital Management LP raised its holdings in shares of MetLife by 4.7% during the fourth quarter. Snow Capital Management LP now owns 1,204,905 shares of the financial services provider’s stock worth $60,920,000 after purchasing an additional 53,883 shares during the last quarter. QUANTRES ASSET MANAGEMENT Ltd purchased a new position in shares of MetLife during the fourth quarter worth $1,279,000. CHURCHILL MANAGEMENT Corp raised its holdings in shares of MetLife by 35.8% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 28,309 shares of the financial services provider’s stock worth $1,431,000 after purchasing an additional 7,470 shares during the last quarter. Finally, Griffin Asset Management Inc. raised its holdings in shares of MetLife by 10.7% during the fourth quarter. Griffin Asset Management Inc. now owns 81,776 shares of the financial services provider’s stock worth $4,135,000 after purchasing an additional 7,916 shares during the last quarter. 77.66% of the stock is owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: This story was first reported by Week Herald and is the property of of Week Herald. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://weekherald.com/2018/04/24/valuengine-lowers-metlife-met-to-hold.html.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.